*  China USP Orlistat Steroids for Women to Lose Weight Fast 96829-58-2 - China Orlistat, Fat Lossing
Use:An antiobesity agent. A pancreatic lipase inhibitor. Antiobesity agent. Antidiabetic;Orlistat is an antiobesity agent. ... However, due to its relative simplicity and stability, orlistat was chosen over lipstatin for development as an anti-obesity ... However, due to its relative simplicity and stability, orlistat was chosen over lipstatin for development as an anti-obesity ... Orlistat is a non-systemic effects of anti-obesity drugs for specific gastrointestinal lipase inhibitor, combined with dietary ...
  http://pharmagear.en.made-in-china.com/product/gBtJdZVbSOcW/China-USP-Orlistat-Steroids-for-Women-to-Lose-Weight-Fast-96829-58-2.html
*  Obesity Medication
... , Appetite Suppressants, Appetite Depressants, Anti-Obesity Agents. ... Agents, Anti-Obesity, Agents, Antiobesity, Anti Obesity Agents, Anti Obesity Drugs, Anti-Obesity Agents, Anti-Obesity Drugs, ... ANTIOBESITY AGENTS, anti-obesity agents (medication), anti-obesity agents, anti obesity drug, antiobesity drug, anti obesity ... Antiobesity Agents, Antiobesity Drugs, Drugs, Anti-Obesity, Drugs, Antiobesity, ...
  http://www.fpnotebook.com/legacy/Endo/Obesity/ObstyMdctn.htm
*  The relationship between BMI and the prescription of anti-obesity medication according to social factors: a population cross...
General practiceAnti-obesity agentsSocioeconomic factorsWeight lossObesityMulti-level modelling ... are more likely to be prescribed anti-obesity medication.. What is already known on this topic. Anti-obesity medication has ... relate uptake of anti-obesity medications to need and; 2) quantify the amount of variation in prescribing of anti-obesity ... Prescribing of anti-obesity medication reflected obesity prevalence across urban/rural areas and deprivation. There was an ...
  https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-87
*  Xenical - Uses, Side Effects, Interactions - MedBroadcast.com
Orlistat belongs to a class of medications known as anti-obesity agents, specifically gastrointestinal lipase inhibitors. When ... Orlistat belongs to a class of medications known as anti-obesity agents, specifically gastrointestinal lipase inhibitors. When ...
  http://www.medbroadcast.com/drug/getdrug/xenical
*  Anti-Obesity Agents - Antiobesity Drugs Summary Report | CureHunter
Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and ... Agents, Anti-Obesity; Agents, Antiobesity; Agents, Weight-Loss; Anti Obesity Agents; Anti Obesity Drugs; Drugs, Anti-Obesity; ... Anti-Obesity Agents (Antiobesity Drugs). Subscribe to New Research on Anti-Obesity Agents ... Antiobesity Drugs; Anti-Obesity Drugs; Antiobesity Agents; Weight-Loss Drugs; ...
  http://www.curehunter.com/public/keywordSummaryD019440-Anti-Obesity-Agents-Antiobesity-Drugs.do
*  Patent US6673815 - Substituted acid derivatives useful as antidiabetic and antiobesity agents ... - Google Patents
and a lipid-lowering agent, a lipid modulating agent, an antidiabetic agent, an anti-obesity agent, an antihypertensive agent, ... one or more anti-obesity agents, and/or one or more lipid-lowering agents, one or more lipid modulating agents (including anti- ... one or more agents for treating arthritis, one or more anti-osteoporosis agents, one or more anti-obesity agents, one or more ... anti-obesity agents, antihypertensive agents, platelet aggregation inhibitors, and/or anti-osteoporosis agents, which may be ...
  http://www.google.com/patents/US6673815?dq=6,757,682
*  Garcinia cambogia (Hydroxycitric Acid) as a Potential Antiobesity Agent | Nutrition | JAMA | The JAMA Network
National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA. ... National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA. ... Garcinia cambogia (Hydroxycitric Acid) as a Potential Antiobesity AgentA Randomized Controlled Trial. ... as a Potential Antiobesity AgentA Randomized Controlled Trial. JAMA. 1998;280(18):1596-1600. doi:10.1001/jama.280.18.1596 ...
  https://jamanetwork.com/journals/jama/fullarticle/188147
*  The Antiobesity Effect of Polygonum aviculare L. Ethanol Extract in High-Fat Diet-Induced Obese Mice
J. Ahn, H. Lee, S. Kim, J. Park, and T. Ha, "The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling ... Clinically available antiobesity agents include orlistat, a pancreatic lipase inhibitor, and sibutramine, a centrally acting ... H. Choi, H. Eo, K. Park et al., "A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling ... F. Lei, X. N. Zhang, W. Wang et al., "Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced ...
  https://www.hindawi.com/journals/ecam/2013/626397/
*  Patent US7718400 - Methods of increasing lean tissue mass using OB protein compositions - Google Patents
Anti-obesity agents. WO1997000319A2. Jun 11, 1996. Jan 3, 1997. Smithkline Beecham Plc. Chimeric leptin fused to immunoglobulin ... Thus, OB protein has the capacity to act, in addition to acting as a weight reducing agent, as an agent affecting lean tissue ... additives such as detergents and solubilizing agents (e.g., Tween 80, Polysorbate 80), anti-oxidants (e.g., ascorbic acid, ... The therapeutic agent could also be given in a film coated tablet and the materials used in this instance are divided into 2 ...
  http://www.google.com/patents/US7718400?dq=3657699
*  Patent US20070269522 - Transdermal Drug Delivery Device with Translucent Protective Film - Google Patents
... drug delivery device comprising a reservoir comprising a releasably stored dosage of a pharmaceutically active agent and a ... anticancer agents (e.g., methotrexate); neurologic agents such as anxiolytic drugs; hemostatics; anti-obesity agents; and the ... Transdermal dosage form comprising an active agent and a salt and free-base form of an adverse agent. ... antimigraine agents (e.g., ergotamine, melatonin, sumatripan); antiarrhythmic agents (e.g., flecainide); antiemetics (e.g., ...
  http://www.google.ca/patents/US20070269522
*  Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide...
Hypoglycemic Agents. Physiological Effects of Drugs. Appetite Depressants. Anti-Obesity Agents. Amylin Receptor Agonists. ... Number of Participants With Treatment Emergent Positive Anti-leptin Antibody Titers at Week 52 and at Follow up by Metreleptin ...
  https://clinicaltrials.gov/show/NCT00819234
*  Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients - Full Text View - ClinicalTrials.gov
Obesity. Anti-Obesity Agents. Carbonic Anhydrase. Carbonic Anhydrase Inhibitors. Enzyme Inhibitors. Sulfonamides. Therapeutic ... Sleep Apnea Obstructive Sleep Apnea Obesity Drug: Zonisamide Drug: Placebo Device: nCPAP Phase 2 ... Obesity. Apnea. Overweight. Overnutrition. Nutrition Disorders. Body Weight. Signs and Symptoms. Respiration Disorders. ...
  https://clinicaltrials.gov/ct2/show/NCT01765608?cond=%22Sleep+Apnea+Syndromes%22&rank=8
*  Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine - Full Text View - ClinicalTrials...
Neurotransmitter Agents. Serotonin Agents. Anticonvulsants. Neuroprotective Agents. Protective Agents. Anti-Obesity Agents. ... Autonomic Agents. Peripheral Nervous System Agents. Physiological Effects of Drugs. Gastrointestinal Agents. Antipsychotic ... Tranquilizing Agents. Central Nervous System Depressants. Psychotropic Drugs. Serotonin Uptake Inhibitors. Neurotransmitter ...
  https://clinicaltrials.gov/ct2/show/NCT00394095
*  The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes - Full Text View - ClinicalTrials.gov
Hypoglycemic Agents. Physiological Effects of Drugs. Appetite Depressants. Anti-Obesity Agents. Amylin Receptor Agonists. ...
  https://clinicaltrials.gov/ct2/show/NCT00206297
*  Detoxification and Treatment of Subjects With Medication Overuse Headache - Full Text View - ClinicalTrials.gov
Neuroprotective Agents. Protective Agents. Physiological Effects of Drugs. Anti-Obesity Agents. Serotonin Receptor Agonists. ...
  https://clinicaltrials.gov/ct/show/NCT00432549?order=29
*  Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults - Full...
Neuroprotective Agents. Protective Agents. Anti-Obesity Agents. To Top. *For Patients and Families ... Antipsychotic Agents. Tranquilizing Agents. Central Nervous System Depressants. Physiological Effects of Drugs. Psychotropic ...
  https://clinicaltrials.gov/ct2/show/NCT00550394
*  The Effect of Xenical on Weight and Risk Factors - Full Text View - ClinicalTrials.gov
Anti-Obesity Agents. To Top. *For Patients and Families. *For Researchers. *For Study Record Managers ... Obesity. Heart Diseases. Overnutrition. Nutrition Disorders. Overweight. Body Weight. Signs and Symptoms. Cardiovascular ... Obesity is associated with numerous chronic diseases and increased cardiovascular mortality. It is also an independent risk ... one risk factor for cardiovascular disease OR overweight/obese individuals with type 2 diabetes on standard hypoglycemic agents ...
  https://clinicaltrials.gov/ct2/show/NCT00152360
*  New Treatment for Alcohol and Nicotine Dependence - Full Text View - ClinicalTrials.gov
Anti-Infective Agents, Local. Anti-Infective Agents. Central Nervous System Depressants. Physiological Effects of Drugs. ... Autonomic Agents. Peripheral Nervous System Agents. Nicotinic Agonists. Cholinergic Agonists. Cholinergic Agents. ... Neurotransmitter Agents. Molecular Mechanisms of Pharmacological Action. Anticonvulsants. Neuroprotective Agents. Protective ... Hence, due to this unique anti-withdrawal effect of topiramate, we propose to adopt the same methodology for treating alcohol- ...
  https://clinicaltrials.gov/ct2/show/NCT01182766
*  Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study - Full Text View - ClinicalTrials.gov
Autonomic Agents. Adrenergic Agents. Adrenergic Uptake Inhibitors. Anti-Obesity Agents. To Top ... Sensory System Agents. Peripheral Nervous System Agents. Antidepressive Agents, Second-Generation. Antidepressive Agents. ... Dopamine Agents. Neurotransmitter Agents. Cytochrome P-450 CYP2D6 Inhibitors. Cytochrome P-450 Enzyme Inhibitors. Enzyme ...
  https://clinicaltrials.gov/ct2/show/NCT01359930?recr=Open&cond=amphetamine+
*  Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine - Full Text View -...
... nonsteroidal anti-inflammatory drugs (NSAIDs) daily, opioids, agents for insomnia (e.g., Ambien, diphenhydramine-containing OTC ... Neuroprotective Agents. Protective Agents. Physiological Effects of Drugs. Anti-Obesity Agents. To Top ... Onset of migraine occurred after age 50 years, or overuse of analgesics or migraine specific agents for the acute treatment of ...
  https://clinicaltrials.gov/ct2/show/NCT03280342?term=Migraine&
*  A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to...
Neuroprotective Agents. Protective Agents. Physiological Effects of Drugs. Anti-Obesity Agents. To Top ... partial-onset seizures who are taking one or two standard anti-epileptic drugs. ...
  https://clinicaltrials.gov/ct2/show/NCT00236860?cond=%22Epilepsies%2C+Partial%22&rank=7
*  Biomedical & Health Informatics
Anti-Aging Skin Care - Wound Care Europe 2018 (Italy). *Applied Health Economics and Health Policy - Health Economics 2018 ( ... Disease Causing Agents - Tropical Diseases Congress 2018 (Spain). *Disease prevention and health promotion interventions - ... Obesity & Public Health - Global Public Health 2018 (Hong Kong). *Obesity & Public Health - Public Health Summit 2018 (Japan) ...
  https://publichealthcongress.conferenceseries.com/events-list/biomedical-health-informatics